If Medicare decides to cover the controversial Alzheimer's drug, the price drop could benefit program costs.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}